cellvie
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $11M
Investors
- 2
About cellvie
Based in the US, cellvie Inc.Founded in 2018 and headquartered in Houston, US, cellvie Inc. focuses on developing advanced mitochondrial therapies. The company has undergone no notable pivots in its business strategy. The founder and CEO, Alexander Schueller, has a background in biotechnology and was involved in previous ventures.cellvie Inc. specializes in Therapeutic Mitochondria Transplantation, a treatment aimed at addressing cellular energy metabolism deficiencies. The company focuses on innovative therapies derived from mitochondria, targeting ischemia-reperfusion injury—a critical condition prevalent in heart attacks, strokes, and kidney transplants.cellvie's revenue model is centered around B2B partnerships with healthcare institutions, aiming to commercialize its Therapeutic Mitochondria Transplantation technology. The company plans to generate income through negotiated contracts based on treatment volumes, particularly focusing on kidney transplantation applications. This model is anticipated to be crucial, especially concerning delayed graft function, which affects a notable percentage of kidney transplant recipients.5 mn, the company plans to utilize the funds to support the development of its technology platform, accelerate team expansion, and enhance mitochondria manufacturing capabilities. As part of its growth strategy, cellvie aims to launch new therapeutic products targeting cellular energy deficiencies and plans to expand its market reach in both North America and Europe.
Who invested in cellvie
2 investors across 3 rounds
See all investors in cellvie
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about cellvie
Who invested in cellvie?
cellvie has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has cellvie raised?
cellvie has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did cellvie last raise money?
cellvie's most recent round on record is a Series A, in Feb 2023.
What does cellvie do?
cellvie is a biotechnology company.
Where is cellvie headquartered?
cellvie is headquartered in Houston, US.
Which VCs invest in companies like cellvie?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at cellvie's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like cellvie? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.